CombiMatrix Q4 Revenues Spike 18 Percent on Prenatal Array Testing Growth | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix today said that revenues in the fourth quarter jumped 18 percent year over year as revenues from core prenatal testing markets increased 57 percent.

For the three months ended Dec. 31, 2013, the Irvine, Calif.-based genetic testing laboratory saw revenues increase to $1.8 million from $1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.